NiFe-layered double hydroxide nanoparticle for co-delivery of DOX and siRNA to overcome multidrug resistance in MCF-7/ADR cells

Yan-Ni Bao,Xiu-Li Xie,Li-Li Lu,Wen-Hao Liu,Yu-Chen Ma,Yi-Jun Ke,Huan Ren,Li-Na Tan,Li-Fang Wu,Jue Song,Yong Jin,Xiao-Yan Liu
DOI: https://doi.org/10.1016/j.jddst.2023.104829
IF: 5
2023-08-09
Journal of Drug Delivery Science and Technology
Abstract:Multidrug resistance (MDR) continues to be the major limiting factor in the cure of patients with cancer. Studies have shown that tumor multidrug resistance may be closely related to the multidrug-resistant protein secreted by itself, such as breast cancer resistance protein (BCRP). Therefore, inhibiting the production of multidrug-resistant proteins through genetic intervention may reverse tumor drug resistance. Herein, we use layered double hydroxide nanoparticles (LDH) to co-deliver DOX and siRNA targeting BCRP RNA to reverse the resistance of MCF-7/ADR cells and enhance the anticancer activity of doxorubicin (DOX). In this platform, DOX is encapsulated in the nanoparticles, which have the characteristics of high drug loading and strong controlled-release, and siRNA is tightly adsorbed on the surface of the nanoparticles through electrostatic action to avoid the degradation of siRNA. Moreover, NiFe-LDH shows excellent ability to deliver siRNA and DOX into cells and enhance the internalization of siRNA and DOX. The experiment further confirms that (1:1) shows an effective gene silencing effect and down-regulated the expression of BCRP. In vitro experiments show that inhibits cell proliferation by affecting the cell cycle and inducing apoptosis. In vivo experiments, MCF-7/ADR xenotransplantation therapy also reveals that has a significant antitumor effect. We believe that this work has great potential for reversing the drug resistance of breast cancer and improving the effectiveness of chemotherapy. Graphical abstract Download : Download high-res image (378KB) Download : Download full-size image According to International Association for the Study of Pain (IASP), the definition of pain is "an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage." Pain aids as a protective role in the alertness of a person in case of tissue injury as well as threats to bodily integrity and survival. Moreover, deprivation of the existence of pain as a priority health condition from so many years has caused less understanding of the mechanism and pain management as well as affecting the development along with the execution of advanced therapies. Nowadays, progress is underway to modulate the classical view of pain and aiming for its recognition as a genuine health problem or better as a unique medical disease rather than a symptom of a disease. Nanomedicine-based technologies can also become useful in the diagnosis of the disease. For the repairing or healing of the damaged nerve tissue, spinal cord injuries and other types of injuries like bone and cartilage which are related to extreme pain, advancements in tissue engineering are very useful. There are various types of nanomedicines either increase the advantages or decrease the limitations of the present formulations. This reviewed chapter highlights the types of pain, the mechanism behind pain perception, and outbreak research prevailing in nanomedicine for management of pain in patients. Drug loading is a key procedure in the preparation of drug-loaded nano-carriers. In this study, the paclitaxel (PTX)-loaded polymeric complex micelles (FA-P123-PTX/PTX micelles) with double drug-loading strategies were designed and prepared to improve the drug loading percentage of carriers and its anti-tumor efficiency. PTX was simultaneously conjugated to pluronic P123 (P123) polymer and encapsulated inside the P123 complex micelle. Folate (FA) was linked to the surface of micelles for the active target delivery of micelles to tumor cells. The FA-P123-PTX/PTX micelles showed spherical shaped with high drug loading of 18.08 ± 0.64%. The results of cellular uptake studies suggested that FA could promote the internalization of micelles into the FR positive cells. FA-P123-PTX/PTX micelles showed significant higher anti-tumor activity against FR positive tumor cells compared to Taxol ® ( p < 0.05). Moreover, the FA-P123-PTX/PTX micelles exhibited higher anti-tumor efficacy in B16 bearing mice with better safety property compared with Taxol ® . These results suggested that FA-P123-PTX/PTX micelles with double drug-loading strategies showed great potential for targeted delivery of anti-cancer drugs. Melanoma is a highly invasive malignant skin tumor having high metastatic rate and poor prognosis. The biology of melanoma is controled by miRNAs. The miRNA-183 cluster, which is composed of miRNA-183∼96∼182 genes, plays an important roles in tumor development. In order to investigate the role and action -Abstract Truncated-
pharmacology & pharmacy
What problem does this paper attempt to address?